Fulton Breakefield Broenniman LLC Sells 26,855 Shares of Danaher Corporation (NYSE:DHR)

Fulton Breakefield Broenniman LLC lowered its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 26.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 72,900 shares of the conglomerate's stock after selling 26,855 shares during the quarter. Fulton Breakefield Broenniman LLC's holdings in Danaher were worth $14,944,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Financial Security Advisor Inc. grew its position in Danaher by 2.1% in the 1st quarter. Financial Security Advisor Inc. now owns 4,296 shares of the conglomerate's stock valued at $882,000 after purchasing an additional 89 shares during the period. Platform Technology Partners acquired a new stake in Danaher in the 1st quarter valued at $220,000. Arizona State Retirement System grew its position in Danaher by 1.4% in the 1st quarter. Arizona State Retirement System now owns 190,771 shares of the conglomerate's stock valued at $39,108,000 after purchasing an additional 2,565 shares during the period. Kathmere Capital Management LLC grew its position in Danaher by 25.6% in the 1st quarter. Kathmere Capital Management LLC now owns 1,118 shares of the conglomerate's stock valued at $229,000 after purchasing an additional 228 shares during the period. Finally, Fort Sheridan Advisors LLC grew its position in Danaher by 5.6% in the 1st quarter. Fort Sheridan Advisors LLC now owns 1,252 shares of the conglomerate's stock valued at $257,000 after purchasing an additional 66 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on DHR shares. TD Cowen raised their price objective on Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a research note on Wednesday, April 23rd. Robert W. Baird dropped their price objective on Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Argus dropped their price objective on Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. UBS Group lowered their target price on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Finally, Leerink Partners boosted their price objective on Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a research note on Wednesday, April 23rd. Three research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. According to data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $248.43.

Insiders Place Their Bets

In related news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president owned 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman directly owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.

Danaher Price Performance

Shares of DHR traded down $0.71 during midday trading on Friday, hitting $204.80. 2,369,010 shares of the company traded hands, compared to its average volume of 3,508,130. The stock has a 50-day moving average of $196.05 and a 200-day moving average of $206.30. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70. The firm has a market cap of $146.57 billion, a P/E ratio of 39.77, a PEG ratio of 2.88 and a beta of 0.77. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.63%. Danaher's payout ratio is presently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.